Our discovery of human papillomavirus type 47 (HPV47) in benign lesions from a patient suffering from epidermodysplasia verruciformis prompted us to examine whether the viral DNA also resided in malignant lesions from the same patient. By using newly devised protocols for amplifying a group of epidermodysplasia verruciformis-associated HPV DNAs by PCR and differentially identifying them by reverse-phase dot blot hybridization, we demonstrated that HPV47 DNA, but not other HPV DNAs of the group, was abundant (about 10 3 copies per diploid amount of cell DNA) in DNAs prepared from three carcinomas. Using DNA from one of these carcinomas, we also confirmed that DNA of HPV5, HPV14, or HPV21, detected in significant amounts in DNAs from benign lesions from the patient, were present only in negligible amounts or not at all. The results suggest the involvement of HPV47 DNA in tumorigenesis. Furthermore, we demonstrated by the Southern technique that most, if not all, of the HPV47 DNA consists of either a unit (or a nongrossly deleted unit) length of the viral genome carrying no (or no gross) internal rearrangements or tandem repeats. This and other results obtained by this technique indicated that a considerable amount of the viral DNA resides as a circular monomer a unit length of the viral genome in carcinoma cells, while the remainder reside as catenanes, concatemers, or both. The concatemers were considered more likely to be replicated without integration into cellular DNA than to be integrated, because no bands for the corresponding fragments including integration sites were detected by treatment with restriction enzymes that would have produced such fragments.
Human papillomavirus type 47 (HPV47) is a member of the HPVs associated with epidermodysplasia verruciformis (EV). These viruses comprise more than 18 types (4). The first isolation of HPV47 DNA was made from an extract of scrapings collected from a variety of lesions clinically considered benign (hereafter called benign lesions) from a patient suffering from EV (1) . This virus was later found to be closely related, in terms of its DNA sequence homology (9) and the transforming activity of its E6 gene (10) , to HPV5 and HPV8, whose DNAs predominate over other related HPV DNAs in cutaneous carcinomas accompanied by EV and, accordingly, are considered ''high-risk'' types (6, 15) . These findings indicate that HPV47 is no less risky than HPV5 and HPV8 regarding carcinogenicity and prompted us to ask whether HPV47 DNA is propagated in EV-accompanied carcinomas. For this purpose we examined surgically excised carcinomas from the patient mentioned above. We also determined the types of HPVs residing in benign lesions from the same patient and further examined whether they were present in a carcinoma. To achieve our aims, (i) we had to determine the nucleotide sequences of the E7 genes of various EV-associated HPVs, and (ii) we had to devise new protocols, including one adapting a PCR for the amplification of DNA segments of EV-associated HPVs from even damaged DNA in archival histological specimens, to facilitate identification by reverse hybridization (5) .
MATERIALS AND METHODS
Patient history and designation of DNA preparations from patient materials. In 1987, a skin ulcer appeared in the right temporal region of the patient from whose benign lesion we had discovered HPV47 (1) , and the skin ulcer was histologically diagnosed as a squamous cell carcinoma (hereafter called C87). Accordingly, the area of the skin including the ulcer was surgically removed and an autologous skin graft was transplanted to the area. The material that was removed was formalin fixed and was processed for conventional histological analysis. Under the microscope, clusters of abnormal cells, heterogeneous in nuclear size and hematoxylin stainability, were noted to be infiltrating from the epidermis into the dermis and forming nests, some of which showed a tendency for cornification and so-called pearl formation. These cells were interpreted as being cancer cells (hereafter called cancer cells) and were surrounded by fibroblastic cells, which made up the major component of the tumor mass. When the present analysis was planned, only a formalin-fixed and paraffin-embedded preparation was available for C87. Twenty-eight serial sections (thickness, 10 m) were prepared from the fixed preparation, and a few sections chosen from the series at appropriate intervals were stained with hematoxylin-eosin. Areas of cancer cells forming nests infiltrating into the dermis were easily recognizable even with the naked eye since they were strongly stained with hematoxylin. The corresponding areas of nonstained sections could therefore be identified by superimposing them on the stained sections, and they were carefully cut out with a surgical knife to avoid contamination with cells from neighboring benign lesions. The DNA was extracted from clusters of cells thus obtained and was named C87 DNA. Thereafter, a tumor arose under the transplanted skin area mentioned above. In 1990, the tumor (hereafter called C90) was examined histologically and was found to be the same as C87, except that invading tumor cells were in contact with the periosteum and were thus considered to be a recurrent carcinoma. The tumor together with neighboring, apparently healthy skin was excised, and the central portion of the excised tumor was cut out from the inner skin surface in the shape of cylinder (4 mm in diameter and ca. 1.5 cm in height), taking care to avoid contact with neighboring epidermal tissue. The cylinder was divided into two semicylinders; one was used to provide C90 DNA and the other was used for conventional histological analysis. Quite independently from the above, a tubercle carrying an ulcer in its center arose in the left parieto-occipital region of the patient's skin, and in 1993, the tubercle (hereafter called C93) was histologically analyzed and was found to be similar to C90. A relatively large area of skin including the tubercle and the underlying subcutaneous tissues including the periosteum was excised. The tissue was carefully gouged out from the rather deeply infiltrated part of the lesion, and DNA was extracted and was named C93 DNA.
Origins of HPV DNAs. The origins of cloned DNAs of HPV3, HPV5, HPV8, HPV14, HPV20, and HPV25 were described earlier (10) , and cloned DNAs of HPV12 (14) , HPV9 (13) , and HPV17 (12) were provided in the form inserted into bacterial plasmids at unique cutting sites: HindIII, BamHI, and BamHI, respectively.
DNA preparation and quantification methods. DNAs from the paraffin-embedded materials were prepared as described by Impraim et al. (8) , and DNAs from all the other human materials were prepared as described previously (23) . Plasmid DNAs were propagated and purified by CsCl density gradient centrifugation as described previously (20) . The DNAs extracted from human materials were quantified by a modified diphenylamine procedure (2) , and other DNAs were quantified by measurement of A 260 .
Primers. The following oligodeoxynucleotides were chemically synthesized to amplify the indicated segments of viral or cellular DNAs. Primer EV3 (5Ј-ATGATTGGTAAAGAGGTCAC-3Ј) corresponds to the sense strand of coordinates 668 to 687 of HPV47 DNA (or 20 nucleotides starting from the first ATG codon of the E7 open reading frame [ORF]); primer EV4 (5Ј-TTAGGATC CGCCATGTTTGC-3Ј) corresponds to the antisense strand of coordinates 960 to 979 (or the last 17 nucleotides of the E7 open reading frame and then the terminal stop codon). Primer S5 (5Ј-GGCTGAGGGAGCCGAACACC-3Ј) corresponds to the sense strand of the HPV5 DNA coordinates 202 to 221. Primer S14/21 (5Ј-GTGCTGACGAAGGTCCTTCT-3Ј) corresponds to the sense strand of HPV14 coordinates 232 to 251, and that of HPV21 DNA corresponds to coordinates 226 to 245 (where the first nucleotide of the HpaI recognition site, A, is presumed to be the beginning of the coordinates of these DNAs). Primer S14/21 is the same as the corresponding region of HPV21 DNA and differs from the corresponding region of HPV14 DNA at only 2 of 22 nucleotides, so that primer S14/21 can serve as a competent primer to amplify this region of HPV14 DNA as well as that of HPV21.
EVE7FBg (5Ј-AGAGATCTACATGATTGGTAAAGAGGTCAC-3Ј) is primer EV3 linked to a BglII recognition sequence at its 5Ј end. EVE7RBg (5Ј-GAA GATCTTTAGATGTACT-3Ј) comprises the nucleotide sequence of the antisense strand of HPV47 DNA between coordinates 984 and 997 and is linked to a BglII recognition sequence at its 5Ј end.
The primer pair used for amplification of a segment of the human beta-globin gene (KM29 and KM38) was described previously (19) .
PCR. The PCR mixture contained 1 U of Taq DNA polymerase (Promega Co. Ltd.), 50 pmol of the appropriate primers, and the indicated amount of DNA as template in 5 l, so that the total volume was 50 l. Other elements in the mixture were as described by the supplier of the polymerase. When not otherwise stated, the reaction was repeated for 35 cycles in a programmed incubator (PC700; ASTEC Co. Ltd.), with each cycle consisting of incubations at 94ЊC for 1 min, 60ЊC for 2 min, and 72ЊC for 3 min, except that the first incubation at 94ЊC was performed for 5 min and the last one at 72ЊC was performed for 10 min.
For cloning and sequencing of E7 fragments of the various HPVs described below, PCR was performed with Pfu polymerase (Stratagene) under the conditions recommended by the supplier and the amplification reaction was limited to 20 cycles, each of which was the same as those given above except that the annealing step was carried out at 37ЊC instead of at 60ЊC.
Reverse-phase dot blot hybridization for identifying PCR-amplified DNA. After 35 cycles of PCR, the reaction mixture was processed through an ultrafiltration device (Suprec-2; Takara Brewer Co. Ltd.) to eliminate unused primers and deoxynucleotides. The amount of the amplified DNA (312 bp) in the samples was roughly estimated by comparison of the intensities of the ethidium bromide-stained electrophoretic bands of the samples with those of various amounts of a marker DNA fragment (298 bp) in the same gel. In order to label a series of amplified DNAs, one cycle of replication with a radioactive substrate was used. For this purpose the filtered samples, which were equal in volume, were transferred to new microtubes so that a few nanograms was the maximum amount of the amplified DNA that was transferred. The samples in the microtubes were subjected to procedures similar to those described previously for the preparation of radioactive probes (11) , except that the primers were the same as those used in the PCR described above (2 pmol) and that [␣-32 P]dCTP (20 Ci; 3,000 Ci/mmol) was used as the radioactive substrate. Then, the reaction mixtures were treated by filtration as described above, and equal volumes were transferred to hybridization bags containing standard HPV DNAs dot blotted onto membrane filters (GeneScreen Plus; DuPont) and treated as described previously (11) . The membranes were washed under the conditions indicated in the figure legends. The labeled DNA hybridized with the dot blotted DNA was visualized, and its intensity was estimated with an image analyzer system (BAS2000; Fuji Photo Film Co. Ltd.).
Cloning and sequencing of E7 fragments of HPVs 12, 14, 20, 21, and 25. Individual plasmid DNAs (100 ng) containing full genomes of HPVs 12, 14, 20, 21, and 25 as templates together with a pair of nucleotide primers (EVE7FBg and EVE7RBg; 100 pmol each) were subjected to PCR under the conditions described above. After treatment with BglII, PCR products were cloned into the BglII site of pTZ18R into which a BglII 8-mer linker (NEB) had been inserted at the HincII site. Both strands of the cloned fragments were sequenced by the dideoxy chain termination method (21) as described previously (9) . The genomic sequence of HPV12 corresponding to the sense primer EV3 required determination. Accordingly, the 2.2-kb PstI fragment of HPV12 DNA was subcloned into pTZ18R and was subjected to dideoxy chain termination sequencing.
Computer programs used to interpret nucleotide sequence data. Homology indices for the E7 nucleotide sequences of the different HPVs were calculated with the algorithm provided by GENETYX Program HOMOGAPN (Software Development Corp., Tokyo, Japan). Phylogenetic trees of E6 and E7 were constructed by using the ''malign'' program, originally devised by J. Hein (7) and modified by Y. Ina (8a) .
Nucleotide sequence accession numbers. The nucleotide sequences of the E7 regions of HPV12, HPV14, HPV20, HPV21, and HPV25 have been submitted to GenBank (accession numbers D50545, D50546, D50547, D50548, and D50549, respectively).
RESULTS

Amplification of E7 segments of eight EV-associated HPV DNAs with a pair of newly designed primers and nucleotide sequence determination of E7 ORFs of three of those DNAs.
We designed a new pair of oligonucleotides, EV3 and EV4, as a promising consensus primer pair for the amplification of ca. 300 bp corresponding to the E7 ORF of EV-associated HPVs. EV3 was designed by consulting sequences of the corresponding DNA segment of seven EV-associated HPVs (10) . The sequence of the corresponding segment of HPV12, which was not included in the seven HPVs, was determined as described in Materials and Methods and was found to be different from that of EV3 by only one internal nucleotide. EV4 was designed by consulting then-available sequences, namely, those of HPV5, HPV8, and HPV47. Our pilot PCR yielded products of the expected size (data not shown), indicating that not only the last three HPV DNAs but also those of HPV12, HPV14, HPV20, HPV21, and HPV25 worked as efficient templates for amplification with the pair of primers mentioned above. To elucidate the nucleotide sequences of the E7 regions of these last five HPVs and to examine to what extent EV4 resembled their corresponding genomic sequences, we attempted to amplify with the primer pair EVE7FBg and EVE7RBg the same segments of HPV DNAs plus 20 to 30 nucleotides extending toward the E2 ORF. All five HPVs yielded amplified DNA bands when they were analyzed by agarose gel electrophoresis. The amplified DNA was cloned and treated to determine the nucleotide sequences. Pairs of DNAs cloned from two independent PCR products of each HPV DNA were found to have exactly the same nucleotide sequence, confirming that the sequence data for the cloned DNAs (Fig. 1a) faithfully reflect the sequences of the HPV genomes. The calculated indices of homology among the different HPV E7 sequences were in the range of 74 to 90%. The amino acid sequences of these five HPV E7 proteins were deduced (data not shown), and a phylogenetic tree (Fig. 1b) was constructed on the assumption that the variations in the amino acid sequences of these E7 proteins had been derived from a hypothetical original sequence. The tree was found to be quite similar to that for the E6 sequences (data not shown).
Evidence that HPV47 DNA is abundant in three carcinomas from the same patient. The PCR experiment described above suggested that EV3 and EV4 could be used as a consensus primer pair for the amplification of the E7 segments of the DNAs from the eight HPV types mentioned earlier, and the series of sequence data for the DNAs of the E7 regions in these HPV types suggested that the eight DNAs were discernible by DNA-DNA hybridization under stringent conditions. Furthermore, the above notion also appeared to be applicable to six additional HPV DNAs (types 19, 22, 23, 36, 46, and 49) since these six types together with the eight types mentioned above are mutually cross-hybridizable under stringent conditions and are classified as D1 group viruses (17) . Accordingly, C87, C90, and C93 DNAs and some control DNA preparations were each subjected to PCR with the EV3 and EV4 primers, and the products were 32 P labeled as described in Materials and Methods. The labeled samples were each subjected to reverse-phase dot blot hybridization. Figures 2a, b , and c show the results for C87 DNA, a control featuring human ovary tumor DNA supplemented with 10 3 copies of standard HPV47 DNA per diploid amount of cell DNA, and the same tumor DNA supplemented with no HPV DNA, respectively. In the PCRs for these DNAs, an additional pair of primers was also included into the reaction mixture so that a segment of human beta-globin gene DNA, which was used as an internal control, would also be amplified. The hybridization conditions for these DNAs were stringent (3 and 5ЊC below the T m for HPV47 DNA and beta-globin DNA, respectively), so that the labeled PCR product from the control sample without HPV DNA provided a strong signal only on the dots of beta-globin DNA (Fig. 2c) and the labeled PCR product from the control sample supplemented with HPV47 DNA provided a strong signal only on dots of beta-globin DNA and HPV47 DNA and a weak signal on DNA dots of the other closely related EV-associated HPVs 5, 8, 12, 14, 20, 21 , and 25 (D1 group), but not on the DNA dots of remotely related EV-associated HPV9 or HPV17 (D2 group) or the DNA dot of HPV3, which induces flat warts (Fig. 2b) . The PCR product from C87 DNA (Fig. 2a) provided exactly the same pattern and intensity as that shown in Fig. 2b , indicating that the number of HPV47 DNA molecules in this DNA preparation was roughly 10 3 copies per diploid amount of cell DNA. Essentially the same autoradiographic results were obtained for C90 and C93 (data not shown). Under the PCR conditions described above, the segment of viral DNAs to be amplified was 312 bp, and a band of DNA, estimated to be ca. 300 bp, was readily observed in ethidium bromide-stained electrophoretograms of the PCR-treated DNAs of C87, C90, or C93, but not in that of the ovary tumor DNA preparation. VOL. 34, 1996 HPV47 DNA IN SKIN CANCERS FROM AN EV PATIENT 371 Figure 2d shows such results for C87. A similarly thick band corresponding to the viral DNA fragment of 312 bp was observed in the lanes for C87 and the control sample supplemented with HPV47, but not in the lane for the control sample not supplemented with HPV47 DNA, supporting the estimation of the quantity of the viral DNA given above. Below the thick band in lane 1 or 2, a weak band of the amplified betaglobin gene fragment, which was used as an internal control, was observed; this band was remarkably weaker than the corresponding band in lane 3, probably because the polymerase was solely engaged in amplification of the beta-globin gene fragment in lane 3. Electrophoretograms of the amplified DNA produced in an experiment in which PCR was limited to 20 cycles further verified the results described above (data not shown). Arrangement of HPV47 DNA in the two carcinomas. The C90 and C93 DNAs were so abundant that they were subjected to Southern blot hybridization by using the whole segment of labeled HPV47 DNA as a probe in order to elucidate the outline of arrangement of HPV47 DNA in the cells of each carcinoma ( Fig. 3 ; data for C90 not shown). When C90 and C93 DNAs were analyzed without any restriction enzyme treatment (lane 2 of Fig. 3a for C93 ), several bands with different mobilities and intensities were observed, indicating that various forms of the viral DNA were present in different amounts. Even when analyzed after treatment with NsiI (lane 1 of Fig. 3a for C93), which happens to have no cleavage sites on HPV47 DNA, the autoradiographic pattern was essentially the same as that without NsiI treatment. The results indicated that the viral DNA is not linked to (or integrated into) cellular DNA, although they could not eliminate the possibility that virus DNAcellular DNA recombination took place such that the NsiI treatment did not change the pattern. When C90 and C93 DNAs were treated with BamHI, which is known to cleave HPV47 DNA at only one site, the autoradiographic results of both preparations gave single bands at the same position as that for the similarly treated normal skin DNA supplemented with pUCHPV47 DNA (which had been constructed by inserting the BamHI-treated linearized HPV47 DNA into the The templates in panels a to c were separately subjected to PCR with the EV3 and EV4 primer pair as described in Materials and Methods. Another pair of primers, KM29 and KM38 (5 pmol of each), was also added to the reaction mixtures described for panels a to c to amplify a segment of the human beta-globin gene as an internal control. Aliquots of these PCR products were labeled and subjected to hybridization (the washing was done with 0. 1 and 2) or BamHI (lanes 3 and 4) and were subjected to hybridization by using the labeled whole HPV47 DNA as a probe. All of the conditions were as described previously (11) , except that autoradiography was performed by using BAS2000. Horizontal bars indicate the sites of the DNA size markers, with numerical values indicating the approximate molecular weights of the markers. Fig. 3b ; the HPV47 segment corresponding to the lowest band was divided into two subsegments in pUCHPV47 DNA, appearing as the uppermost and lowermost ''off-size'' bands with weak intensities). These results indicate that most of the viral DNA consists of either a unit (or nongrossly deleted unit) length of the viral genome carrying no (or no gross) internal rearrangement or tandem repeats of this unit length, although the results cannot eliminate the possibility that undetectable minor portions of the viral DNA comprised grossly deleted and/or grossly rearranged forms. The bands observed with no enzyme treatment (lane 2 of Fig. 3) were interpreted by taking into account the conclusions drawn from the results obtained for the enzyme-treated samples. The second lowest band was considered to be form III (linearized form) monomeric HPV47 DNA, because it was mobilized at the same position as the BamHI-cleaved linearized HPV47 DNA. The lowest band was interpreted as monomeric form I (supercoiled form) because of its position relative to that of form III. The thick band located above the form III band was interpreted as monomeric form II (open circle) because DNA from benign lesion, in which the monomeric forms of viral DNA predominate over multimeric forms, provided a monomeric form II band at the same position (data not shown). A few bands mobilized above that of monomeric form II were interpreted as representing concatemers (tandem repeats of monomers) or catenanes (chains of circularized monomers or concatemers) of viral DNA. A more detailed speculation concerning the arrangement of viral DNA is given in the following section. The band intensity in comparison with that of a known amount of pUCHPV47 DNA in parallel lanes as a standard allowed us to estimate the number of HPV47 DNA molecules in C90 and C93 DNAs to be about 10 3 per diploid amount of cell DNA, showing agreement with the quantification by the PCR technique described above.
for C93 in
EV-associated HPV DNAs found in benign lesions from the patient. Concentrating particles regarded as virions of HPV from a large pool of scrapes from benign lesions from the patient by ultracentrifugation, we clone purified HPV47 DNA as HPV DNA that has not yet been described and HPV21 DNA as HPV DNA that has already been described (1) . At that time, we also recognized a few additional electrophoretic bands of restriction enzyme-cleaved virion DNA which might well be interpreted as bands of HPV5 and HPV14 DNAs (unpublished data). In order to elucidate whether additional types of EV-associated HPVs were actually propagated in the benign lesions from the patient, DNA was extracted from pooled scrapes of benign lesions scattered on the skin of the patient's face (named BLF DNA) and was analyzed by the same amplification and typing procedures used for C87, C90, and C93 DNAs (Fig. 4) . Strong signals were obtained on the dots of HPV5 and HPV14 DNAs, and weaker signals were obtained on the dots of HPV21 DNA. In parallel with BLF DNA, three control DNA preparations in which a comparable amount of ovary tumor DNA was supplemented with 10 3 copies of HPV5 DNA per diploid amount of cell DNA, 10 4 copies of HPV14 DNA per diploid amount of cell DNA, or both HPVs were also examined. Taking all of these results into account, BLF DNA could be interpreted as containing HPV5 and HPV14 DNAs as the major HPV DNA species. The results also led us to consider that HPV21 DNA was present as a minor species. The latter conclusion is based on the fact that the relative intensity of the signal on HPV21 DNA dots to those on HPV5 and HPV14 DNA dots of the BLF DNA membrane was stronger than the relative intensity of control membranes that were purely due to cross-hybridization of radioactive HPV5 and HPV14 DNAs to HPV21 DNA. However, this conclusion remains to be verified. We also examined in the same way DNA preparations extracted from scrapes of 10 well-isolated focal benign lesions found on the skin of the patient's trunk and extremities and obtained hybridization signals indicating the presence of HPV5, HPV21, or HPV47 DNA (data not shown). However, we obtained no signal heralding the presence of HPV8 DNA, which is considered a high-risk type but which has so far never been reported from Japanese patients.
Examination of the possibility that HPV5, HPV14, or HPV21 DNA was also present in C90. The results presented above demonstrate that abundant HPV47 DNA was present in all three malignant lesions and revealed an outline of its intracellular arrangement in two of them. However, these results did not allow for the elimination of the possibility that smaller but biologically significant amounts of other HPV DNAs were also present in these lesions. The HPV DNAs other than HPV47 DNA found in benign lesions from the patient (namely, HPV5, HPV14, and HPV21 DNAs) were considered possible candidates for such minor species of DNA. In order to demonstrate such minor species of DNA, we considered it mandatory to find a stretch of nucleotide sequences that was most variable among the HPV DNAs under investigation and to use them as PCR primers. Our survey of the available DNA sequence data yielded a stretch located close to the first ATG codon of individual E6 genes as a most promising variable sequence, and we named each one, e.g., S5 for the stretch of the sequence in HPV5 DNA. Our pilot experiments indicated that PCR with pairs of primers, one of which was the oligonucleotide corresponding to the variable sequence described above specific for each of these HPV DNAs and the other of which was EV2, a consensus primer (10), was very effective for amplification of minor species of DNA in the presence of no less than a 10 5 -fold excess of HPV47 DNA (data not shown). In order to measure HPV5 DNA as a possible minor species in C90, for instance, an appropriate amount of C90 DNA (10 ng) was subjected to PCR with S5 and EV2 as a pair of primers, (10 pg). The templates described for panels a to d were separately subjected to PCR with a pair of primers, primers EV3 and EV4, as described in Materials and Methods. Aliquots of these PCR products were labeled and subjected to hybridization with duplicate dot-blotted standard HPV DNAs, as described in the legend to Fig. 2 . The chart on the right indicates the layout of standard DNA, as described in the legend to Fig. 2. VOL. 34, 1996 HPV47 DNA IN SKIN CANCERS FROM AN EV PATIENT 373 and the amplified product was labeled and subjected to reverse-phase hybridization with the standard HPV DNA dot blotted onto the membrane filter. The autoradiographic results (Fig. 5a ) gave clear signals only on dots of the standard HPV5 DNA (and no signal on the HPV47 DNA, even though a large amount of HPV47 DNA was available as a template for PCR).
The similarly processed positive control sample comprising the ovary tumor DNA (10 ng) supplemented with HPV47 DNA (10 4 copies per diploid amount of cell DNA) and HPV5 DNA (10 Ϫ1 copies per diploid amount of cell DNA) also provided a slightly stronger signal on dots of HPV5 DNA only (Fig. 5b) , but the negative control sample comprising the ovary tumor DNA supplemented with HPV47 DNA only did not give a signal on the membrane sheet (data not shown). The same type of analysis was done with S14/21 in place of S5 to detect HPV21 and HPV14 DNAs in C90. However, no positive signal was obtained with C90 DNA, whereas clear signals were obtained with the positive control samples (data not shown).
In order to estimate the approximate copy number of HPV5 DNA in C90 cells, the PCR product of C90 DNA, prepared as described above, was subjected to agarose gel electrophoresis; the resultant ethidium bromide-stained band appearing at the site where the amplified HPV5 DNA fragment was expected to migrate was compared with the corresponding band of the PCR product obtained by using as a template the ovary tumor DNA supplemented with HPV47 DNA (10 4 copies per diploid amount of cell DNA) and HPV5 DNA (10 Ϫ1 , 10
Ϫ2
, or 0 copies per diploid amount of cell DNA). The band intensity of C90 DNA was found to be comparable to that of the control with 10 Ϫ2 copies of HPV5 DNA per diploid amount of cell DNA (data not shown). Since it seemed very likely that only cancer cells of the carcinoma carried HPV DNA, we inspected the histology of successively sliced specimens of the remaining semicylinder of C90, scored the numbers of cancer cells (cells forming nests) and other cells, and came to the conclusion that cancer cells occupied no less than 10% of the cells making up the tumor mass. Combining the PCR and histology results presented above, we were able to estimate that only about 10% of the cancer cells could carry one copy of HPV5 DNA, if they could carry any at all, eliminating the possibility that at least one copy of HPV5, HPV14, or HPV21 DNA was present in all of the cancer cells of C90.
DISCUSSION
The major aim of the study described here was to obtain evidence that HPV47 DNA is propagated in carcinoma cells of EV. For this purpose, we examined three carcinomas from the patient in whose benign lesions we had originally discovered the HPV47 virion and its DNA. All three carcinomas showed quite similar histological characteristics, as described in Materials and Methods. C90 was clinically considered to be a recurrence of C87, while C93 was considered to be a carcinoma which had evolved independently from the other two. For DNA extraction, the central parts of the three carcinomas were carefully excised to avoid contamination of the surrounding benign lesions. The PCR and then reverse-phase dot blot hybridization demonstrated that DNAs from these carcinomas contained HPV47 DNA at about 10 3 copies per diploid amount of cell DNA, but they did not contain other related HPV DNAs in comparable amounts. As a basis for the study, the nucleotide sequences of the E7 genes of five EV-associated HPVs, which had not yet been reported, had to be determined, and the sequences of three of these five HPVs are reported here for the first time. Comparison of these sequences together with those previously determined for HPVs 5, 8, and 47 verified the ability of the procedures described above to detect and distinguish EV-associated HPV DNAs in limited amounts.
Southern blot analysis of C90 and C93 DNAs not only confirmed the results obtained by the PCR procedures but also allowed us to speculate about some details of the arrangement of HPV47 DNA in the carcinoma cells; namely, that most, if not all, of the viral DNA consists of either a unit (or a nongrossly deleted unit) length of the viral genome carrying no (or no gross internal) rearrangement or tandem repeats of such unit length. A considerable fraction of viral DNA molecules persists as circular monomers. The remainder joins to build catenanes, concatemers, or both. Further analysis, e.g., with S1 nuclease, has to be performed to determine which of the three alternatives is actually the case. The circular monomer and catenanes (if they are present) must be replicated, by their nature, without being integrated into cellular DNA. Concatemers (if they are present) are also more likely to be replicated without integration because no bands corresponding to fragments including integration sites were detected by treatment with any of the three enzymes that would be expected to produce such fragments. However, there remains the possibility that hybridization could not detect such fragments. The results for HPV47 DNA in the carcinomas examined here are essentially the same as those for HPV5, HPV8, HPV17, and HPV20 reported elsewhere, except that the partially deleted or partially duplicated HPV5 genome was also found to be arranged as a unit so that monomeric and multimeric forms could be constructed in some carcinomas, and the partially deleted genome was found to be integrated into the cellular DNA of the metastatic carcinoma (15, 16, 18, 22, 24, 25) .
For the present we speculate that HPV47 DNA is propagated only in cancer cells, which account for a minor portion of the cells composing C87, C90, or C93, but not other constituent cells. If this assumption is correct, the average number of viral DNA molecules in cancer cells is close to 10 4 per diploid amount of cell DNA. However, as described in Materials and Methods, cancer cells showed variation in their nuclear staining with hematoxylin and a tendency for cornification. This histological evidence suggests the intriguing possibility that HPV DNA molecules may not reside in the same number in all cancer cells, with, for instance, cornifying cells bearing much more viral DNA than less differentiated cells. In situ hybrid- FIG. 5 . Identification of a minor HPV DNA in the presence of a large excess of the major HPV DNA. C90 DNA (10 ng) (a) and ovary tumor DNA (10 ng) supplemented with pUCHPV47 DNA (10 2 pg) and pUCHPV5 DNA (10 Ϫ3 pg) (b) were separately subjected to PCR with the primer pair S5 and EV2, and the amplified products were subjected to hybridization as described in the legend to Fig. 3 , except that the washing was performed with 0.12ϫ SSC at 65ЊC. The chart on the right indicates the layout of standard DNA, as described in the legend to ization experiments to provide some clues to the answer to this question are in progress. HPV5, HPV14, HPV21, and HPV47 were found to reside in benign lesions of the patient, as speculated from our previous unpublished data, but other related HPVs whose DNAs were also used as probes (HPVs 8, 12, 20, and 25) were not. The possibility that HPV DNAs in benign lesions might also be propagated in a carcinoma, C90, in which HPV47 DNA was abundant, was rigorously examined, but no HPV DNAs were detected in such an abundance that each C90 cancer cell could carry at least one viral DNA molecule. In the case of HPV5 DNA, our sensitive assay protocol definitely detected viral DNA molecules at a level of 10 Ϫ2 copies per diploid amount of cell DNA in the presence of no less than a 10 5 -fold excess of HPV47 DNA. The detection of viral DNA molecules at this level in the sample might have been the result of contamination of C90. Even if it is due to a true biological cause, cancer cells were found to comprise about 10% of the cells in the carcinoma, so that a single set of the HPV5 genome would be shared by 10 cancer cells. In other words, 90% or more of the cancer cells are free of an HPV5 genome, supporting the notion that HPV47-infected epidermal cells in benign lesions can be converted to malignant cells without the help of another EV-associated HPV such as HPV5 and that HPV47 may present as high a risk for carcinogenesis as HPV5.
